OnKure Therapeutics, Correlations
| OKUR Stock | 8.05 0.56 6.50% |
The current 90-days correlation between OnKure Therapeutics, and Dogwood Therapeutics, is -0.12 (i.e., Good diversification). The correlation of OnKure Therapeutics, is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak. If the correlation is 0, the equities are not correlated; they are entirely random.
OnKure Therapeutics, Correlation With Market
Modest diversification
The correlation between OnKure Therapeutics, and DJI is 0.28 (i.e., Modest diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding OnKure Therapeutics, and DJI in the same portfolio, assuming nothing else is changed.
OnKure |
Moving together with OnKure Stock
| 0.62 | GRTX | Galera Therapeutics | PairCorr |
| 0.72 | CYCCP | Cyclacel Pharmaceuticals | PairCorr |
| 0.76 | ZBIO | Zenas BioPharma, Common | PairCorr |
| 0.82 | ZIVO | Zivo Bioscience | PairCorr |
| 0.62 | LADX | LadRx | PairCorr |
| 0.84 | ORGS | Orgenesis | PairCorr |
Moving against OnKure Stock
| 0.77 | EVLO | Evelo Biosciences | PairCorr |
| 0.71 | VAXX | Vaxxinity | PairCorr |
| 0.64 | FRTX | Fresh Tracks Therapeutics | PairCorr |
| 0.63 | FBIOP | Fortress Biotech Pref | PairCorr |
| 0.57 | EPRX | Eupraxia Pharmaceuticals | PairCorr |
| 0.47 | GRCE | Grace Therapeutics, Symbol Change | PairCorr |
| 0.37 | ENZN | Enzon Pharmaceuticals | PairCorr |
| 0.33 | CEROW | CERo Therapeutics Symbol Change | PairCorr |
| 0.5 | LBPH | Longboard Pharmaceuticals | PairCorr |
Related Correlations Analysis
| -0.61 | -0.64 | 0.68 | 0.09 | DWTX | ||
| -0.61 | 0.7 | -0.68 | -0.01 | EPRX | ||
| -0.64 | 0.7 | -0.58 | -0.16 | CEROW | ||
| 0.68 | -0.68 | -0.58 | 0.09 | IRD | ||
| 0.09 | -0.01 | -0.16 | 0.09 | TLX | ||
| Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between OnKure Stock performing well and OnKure Therapeutics, Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze OnKure Therapeutics,'s multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.| Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
|---|---|---|---|---|---|---|---|---|---|---|
| DWTX | 7.67 | (0.52) | 0.00 | (0.70) | 0.00 | 15.01 | 69.76 | |||
| EPRX | 3.66 | 0.23 | 0.05 | (0.49) | 3.86 | 10.43 | 34.56 | |||
| CEROW | 26.34 | 5.11 | 0.20 | (1.73) | 22.06 | 66.67 | 191.74 | |||
| IRD | 4.01 | (0.33) | 0.00 | (0.22) | 0.00 | 9.77 | 29.54 | |||
| TLX | 1.67 | 0.18 | 0.07 | (0.94) | 1.72 | 4.38 | 10.19 |
OnKure Therapeutics, Corporate Management
| Kevin Litwiler | Senior Pharmacology | Profile | |
| Jason CPA | Chief Officer | Profile | |
| Pr Liu | Member Board | Profile | |
| Rogan JD | General Secretary | Profile | |
| Dylan Hartley | Chief Officer | Profile | |
| Richard Woessner | Senior Pharmacology | Profile |